Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma
Clinical trial NCT03909412 · RECRUITING
Trial details
- NCT number
- NCT03909412
- Sponsor
- Hackensack Meridian Health
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-08
- Primary completion
- 2026-09-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.